GO:0000033 alpha-1,3-mannosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000033 defines alpha-1,3-mannosyltransferase activity, the enzymatic transfer of a mannose residue to an oligosaccharide to form an alpha-(1->3) linkage.
• This activity is conserved from fungi to humans and is essential for N-linked glycosylation, cell wall integrity, and host-pathogen interactions.
• Key enzymes include MNN1 in Saccharomyces cerevisiae, Cryptococcus neoformans alpha-1,3-mannosyltransferases, and ALG3 in humans.
• In fungal pathogens, alpha-1,3-mannosyltransferase activity is required for immune evasion and virulence, making it a potential antifungal target.
• In humans, ALG3 dysfunction is linked to non-small cell lung cancer malignancy and is regulated by miR-98-5p.
• CRISPR-based knockout, point mutation, and knock-in models enable precise dissection of alpha-1,3-mannosyltransferase function in disease and biotechnology.
Description
Alpha-1,3-mannosyltransferase activity (GO:0000033) is a molecular function that catalyzes the transfer of a mannose residue from a donor substrate to an oligosaccharide acceptor, forming an alpha-(1->3) linkage. This activity is a cornerstone of protein N-glycosylation and cell surface glycan biosynthesis, processes that are critical for protein folding, stability, and cell-cell communication. In fungi, alpha-1,3-mannosyltransferases are essential for building the mannan layer of the cell wall and for evading host immune detection. In humans, the alpha-1,3-mannosyltransferase ALG3 participates in the early steps of N-linked glycosylation, and its dysregulation has been implicated in cancer progression. Understanding this enzymatic activity is therefore relevant to glycobiology, infectious disease, and oncology. Researchers study GO:0000033 using biochemical assays, genetic knockouts, and CRISPR-based editing to define its substrates, regulators, and disease connections.
alpha-1,3-mannosyltransferase activity At A Glance
| GO ID | GO:0000033 |
|---|---|
| GO term | alpha-1,3-mannosyltransferase activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Transfer of mannose to oligosaccharide forming alpha-(1->3) linkage |
| EC number | 2.4.1.- (glycosyltransferase family) |
| Representative genes | MNN1 (S. cerevisiae), CMT1/CMT2 (C. neoformans), ALG3 (human) |
| Pathways | N-linked glycosylation, cell wall mannan biosynthesis |
| Disease links | Fungal virulence, non-small cell lung cancer |
What Is GO:0000033?
According to the Gene Ontology, alpha-1,3-mannosyltransferase activity (GO:0000033) is defined as the catalysis of the transfer of a mannose residue to an oligosaccharide, forming an alpha-(1->3) linkage. In practice, this means the enzyme takes a mannose donor, typically GDP-mannose or dolichol-phosphate-mannose, and attaches the mannose to a specific hydroxyl group on an acceptor sugar chain, creating a new alpha-1,3 glycosidic bond. This activity is distinct from other mannosyltransferase activities that form alpha-1,2, alpha-1,6, or beta linkages.
Why Is alpha-1,3-mannosyltransferase activity Important in Cell Biology?
Alpha-1,3-mannosyltransferase activity is important because it shapes the glycan structures that decorate proteins and lipids on the cell surface, influencing protein folding, stability, and recognition by the immune system. In pathogenic fungi such as Cryptococcus neoformans and Magnaporthe oryzae, this activity is required for building protective mannan layers and for evading host innate immunity, making it a promising antifungal target. In humans, the alpha-1,3-mannosyltransferase ALG3 is involved in congenital disorders of glycosylation and cancer, where its expression correlates with malignancy and is regulated by microRNAs. Thus, understanding GO:0000033 has broad implications for infectious disease, cancer biology, and biotechnology.
• Essential for N-linked glycosylation and protein quality control in the endoplasmic reticulum.
• Required for fungal cell wall integrity and virulence in Cryptococcus neoformans and Magnaporthe oryzae.
• Enables immune evasion by modifying effector proteins with alpha-1,3-mannose residues.
• Dysregulation of ALG3 is associated with non-small cell lung cancer malignancy.
• Target for antifungal drug development due to its role in fungal cell wall biosynthesis.
• Used in glycoengineering to produce humanized glycoproteins in yeast.
• Conserved catalytic motif shared with other glycosyltransferases, aiding functional annotation.
• Potential biomarker for cancer diagnosis and prognosis.
• Facilitates studies of host-pathogen interactions through glycan remodeling.
• Provides a model for understanding glycosyltransferase mechanism and specificity.
What Happens During alpha-1,3-mannosyltransferase activity?
Substrate recognition and donor selection
In simple terms: The enzyme first grabs the mannose donor and the sugar chain it will modify.
Alpha-1,3-mannosyltransferases recognize specific oligosaccharide acceptors, often mannose-containing chains on glycoproteins or glycolipids, and select a mannose donor such as GDP-mannose or dolichol-phosphate-mannose. In Cryptococcus neoformans, the enzyme uses GDP-mannose to add mannose to a mannoprotein acceptor. In Saccharomyces cerevisiae, MNN1 transfers mannose from GDP-mannose to O-linked and N-linked glycans.
Catalytic transfer and alpha-1,3 linkage formation
In simple terms: The enzyme attaches the mannose to the sugar chain, creating a specific alpha-1,3 bond.
The catalytic mechanism involves a conserved motif found in many glycosyltransferases, which coordinates the donor and acceptor to form an alpha-(1->3) glycosidic bond. This step is essential for elongating the mannan backbone in fungal cell walls and for adding mannose to N-glycans in the endoplasmic reticulum. Mutations in the conserved motif abolish enzymatic activity, confirming its role in catalysis.
Product elongation and glycan maturation
In simple terms: After the first mannose is added, the sugar chain can be extended further.
The alpha-1,3-linked mannose serves as a substrate for additional mannosyltransferases, leading to branched mannan structures in fungi or complex N-glycans in humans. In Kluyveromyces marxianus, engineering alpha-1,3-mannosyltransferase activity is part of constructing a human complex-type N-linked glycosylation pathway. In Magnaporthe oryzae, the alpha-1,3-mannosyltransferase adds mannose to effector proteins, which is required for full virulence.
Biological consequences: cell wall integrity and immune evasion
In simple terms: The modified sugar chains help the cell survive and hide from the immune system.
In fungi, alpha-1,3-mannosyltransferase activity is critical for cell wall mannan structure, and loss of this activity leads to reduced virulence and increased immune recognition. In Cryptococcus neoformans, the enzyme is unique and essential for capsule formation and virulence. In rice blast fungus, N-glycosylation of effector proteins by an alpha-1,3-mannosyltransferase is required to evade host innate immunity.
Key Genes Involved in GO:0000033 alpha-1,3-mannosyltransferase activity
The following genes encode enzymes with alpha-1,3-mannosyltransferase activity or are directly involved in its biological processes across model organisms and humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MNN1 (S. cerevisiae) | Alpha-1,3-mannosyltransferase for O- and N-linked glycans | Model for glycosyltransferase motif and function |
| CMT1 (C. neoformans) | Alpha-1,3-mannosyltransferase for mannoprotein | Virulence factor and antifungal target |
| CMT2 (C. neoformans) | Alpha-1,3-mannosyltransferase | Capsule biosynthesis and immune evasion |
| ALG3 (human) | Alpha-1,3-mannosyltransferase in N-glycosylation | Cancer malignancy and miR-98-5p regulation |
| ALG3 (K. marxianus) | Alpha-1,3-mannosyltransferase for glycoengineering | Humanized N-glycosylation pathway construction |
| M. oryzae alpha-1,3-mannosyltransferase | Effector protein N-glycosylation | Host immune evasion and virulence |
| E. coli O9a antigen polymerase | Alpha-1,3-mannosyltransferase-like domain | Biosynthesis of O-antigen and polymerase specificity |
| ATM (human) | Autophagy-lysosomal pathway regulation | Indirect link to glycosylation stress |
How Is alpha-1,3-mannosyltransferase activity Regulated?
Alpha-1,3-mannosyltransferase activity is regulated at multiple levels. In humans, ALG3 expression is negatively regulated by miR-98-5p, and this regulation affects non-small cell lung cancer malignancy. In fungi, the activity is controlled by the availability of GDP-mannose and by the expression of the corresponding genes during cell wall remodeling. Additionally, domain interactions in related polymerases control complex formation and specificity, as shown for the Escherichia coli O9a antigen biosynthesis. ATM loss disrupts the autophagy-lysosomal pathway, which may indirectly affect glycosylation processes.
alpha-1,3-mannosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALG3 | Non-small cell lung cancer | Knockout and overexpression in lung cancer cell lines |
| CMT1 | Cryptococcosis | Knockout in Cryptococcus neoformans |
| CMT2 | Cryptococcosis | Knockout in Cryptococcus neoformans |
| M. oryzae alpha-1,3-mannosyltransferase | Rice blast disease | Knockout in Magnaporthe oryzae |
| MNN1 | Yeast cell wall integrity | Point mutations in Saccharomyces cerevisiae |
Fungal infections and immune evasion
Alpha-1,3-mannosyltransferase activity is essential for the virulence of Cryptococcus neoformans and Magnaporthe oryzae. In C. neoformans, the enzyme is required for capsule formation and mannoprotein modification, and its loss reduces virulence. In M. oryzae, N-glycosylation of effector proteins by an alpha-1,3-mannosyltransferase is necessary to evade host innate immunity, making it a target for antifungal strategies.
Cancer: ALG3 in non-small cell lung cancer
ALG3, a human alpha-1,3-mannosyltransferase, contributes to the malignancy of non-small cell lung cancer and is negatively regulated by miR-98-5p. High ALG3 expression is associated with tumor progression, suggesting that this glycosylation enzyme could be a therapeutic target or biomarker.
Congenital disorders of glycosylation
Defects in alpha-1,3-mannosyltransferase activity can lead to congenital disorders of glycosylation, although specific mutations in ALG3 are rare. The conserved catalytic motif is critical for enzyme function, and its disruption may cause glycosylation defects.
From alpha-1,3-mannosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of alpha-1,3-mannosyltransferase reduce fungal virulence? | Knockout in Cryptococcus neoformans or Magnaporthe oryzae |
| What is the catalytic mechanism of the conserved motif? | Point mutation in MNN1 in S. cerevisiae |
| Can humanized glycosylation be achieved in yeast? | Knock-in of human ALG3 in Kluyveromyces marxianus |
| Does ALG3 overexpression promote cancer malignancy? | Overexpression in non-small cell lung cancer cells |
| How does alpha-1,3-mannosyltransferase affect immune recognition? | Tagged knock-in for localization and interaction studies |
| What is the role of domain interactions in polymerase specificity? | Point mutations in E. coli O9a antigen polymerase |
How to Study the alpha-1,3-mannosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive mannose transfer assay | Enzymatic activity | Biochemical characterization |
| CRISPR knockout | Gene function loss | Virulence and glycosylation studies |
| Site-directed mutagenesis | Catalytic motif function | Mechanistic studies |
| Mass spectrometry | Glycan structure | Glycoengineering and profiling |
| Infection model | Virulence | Antifungal target validation |
| qRT-PCR | Gene expression | Regulation by microRNAs |
| Western blot | Protein expression | Overexpression and knockdown validation |
| Immunofluorescence | Protein localization | Cellular component studies |
Biochemical assays for mannosyltransferase activity
Enzymatic activity of alpha-1,3-mannosyltransferases can be measured using radioactive or fluorescent mannose donors and oligosaccharide acceptors, followed by chromatographic separation of products. These assays are used to confirm enzyme function and to test inhibitors.
Genetic and CRISPR-based perturbation
Knockout, point mutation, and knock-in models in yeast, fungi, and human cell lines allow researchers to dissect the role of alpha-1,3-mannosyltransferase activity in glycosylation, virulence, and cancer. CRISPR-Cas9 is particularly useful for generating precise mutations in the conserved catalytic motif.
Glycan profiling and mass spectrometry
Mass spectrometry and glycan arrays can profile the oligosaccharides produced by alpha-1,3-mannosyltransferase activity, revealing changes in mannan structure and N-glycan composition. These methods are essential for glycoengineering applications.
Infection and immune assays
In fungal pathogens, virulence and immune evasion can be assessed using infection models and immune cell activation assays, comparing wild-type and mutant strains lacking alpha-1,3-mannosyltransferase activity.
How CRISPR Can Be Used to Study GO:0000033 alpha-1,3-mannosyltransferase activity
Knockout
CRISPR knockout of alpha-1,3-mannosyltransferase genes such as ALG3 or CMT1 can abolish enzymatic activity, leading to glycosylation defects and reduced virulence in fungi. These models are used to study loss-of-function phenotypes in cancer and infection.
Point Mutation
Point mutations in the conserved catalytic motif of MNN1 or other alpha-1,3-mannosyltransferases can specifically inactivate the enzyme without affecting protein stability, allowing precise structure-function analysis.
Knock-in
Knock-in of human ALG3 into Kluyveromyces marxianus or other yeast hosts can reconstruct human N-glycosylation pathways for biopharmaceutical production. Tagged knock-in also enables localization and interaction studies.
Overexpression
Overexpression of ALG3 in non-small cell lung cancer cells promotes malignancy, providing a model to study its oncogenic role and regulation by miR-98-5p. Overexpression in yeast can enhance mannan production for industrial applications.
How EDITGENE Supports alpha-1,3-mannosyltransferase activity Research
Researchers studying alpha-1,3-mannosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation, virulence, or cancer. EDITGENE provides CRISPR-based services to generate precise knockout, point mutation, knock-in, and overexpression cell models, along with library screening and bioinformatics support, to accelerate functional validation of GO:0000033-related genes.
Contact EDITGENE today to design your custom CRISPR model for alpha-1,3-mannosyltransferase activity research.
Frequently Asked Questions About alpha-1,3-mannosyltransferase activity
What is alpha-1,3-mannosyltransferase activity?
It is the enzymatic activity that transfers a mannose residue to an oligosaccharide, forming an alpha-(1->3) linkage, as defined by GO:0000033.
What genes are involved in alpha-1,3-mannosyltransferase activity?
Key genes include MNN1 in Saccharomyces cerevisiae, CMT1 and CMT2 in Cryptococcus neoformans, ALG3 in humans, and the alpha-1,3-mannosyltransferase in Magnaporthe oryzae.
What is the GO ID for alpha-1,3-mannosyltransferase activity?
The GO ID is GO:0000033, under the molecular_function ontology.
How is alpha-1,3-mannosyltransferase activity related to disease?
It is required for fungal virulence and immune evasion, and ALG3 dysregulation is linked to non-small cell lung cancer.
What is the function of ALG3?
ALG3 is a human alpha-1,3-mannosyltransferase involved in N-linked glycosylation, and its expression is negatively regulated by miR-98-5p in lung cancer.
Which organisms have alpha-1,3-mannosyltransferase activity?
This activity is found in fungi such as Cryptococcus neoformans, Saccharomyces cerevisiae, Magnaporthe oryzae, and in humans.
How can I study alpha-1,3-mannosyltransferase activity?
You can use biochemical assays, CRISPR knockout, point mutations, knock-in, overexpression, and glycan profiling.
What is the catalytic mechanism of alpha-1,3-mannosyltransferase?
It uses a conserved glycosyltransferase motif to transfer mannose from a donor to an acceptor, forming an alpha-1,3 linkage.
Is alpha-1,3-mannosyltransferase a drug target?
Yes, in fungi it is a potential antifungal target because it is essential for cell wall integrity and virulence.
What cell models are available for alpha-1,3-mannosyltransferase research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell models for genes like ALG3, CMT1, and MNN1.
Conclusion
Alpha-1,3-mannosyltransferase activity (GO:0000033) is a fundamental enzymatic function that builds alpha-1,3-linked mannose structures on glycans, with critical roles in fungal virulence, immune evasion, and human cancer. Its conserved catalytic mechanism and diverse biological functions make it an attractive target for antifungal and anticancer research. By leveraging CRISPR-based models and biochemical assays, researchers can precisely dissect the contributions of this activity to health and disease.
References
- 1. Cheng A et al.. 2021. ATM loss disrupts the autophagy-lysosomal pathway.. Autophagy 17(8):1998-2010 PMID: 32757690
- 2. Sommer U et al.. 2003. An alpha-1,3-mannosyltransferase of Cryptococcus neoformans.. J Biol Chem 278(48):47724-30 PMID: 14504286
- 3. Doering TL. 1999. A unique alpha-1,3 mannosyltransferase of the pathogenic fungus Cryptococcus neoformans.. J Bacteriol 181(17):5482-8 PMID: 10464224
- 4. Wiggins CA et al.. 1998. Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases.. Proc Natl Acad Sci U S A 95(14):7945-50 PMID: 9653120
- 5. Chen XL et al.. 2014. N-glycosylation of effector proteins by an α-1,3-mannosyltransferase is required for the rice blast fungus to evade host innate immunity.. Plant Cell 26(3):1360-76 PMID: 24642938
- 6. Lee MH et al.. 2020. Constructing a human complex type N-linked glycosylation pathway in Kluyveromyces marxianus.. PLoS One 15(5):e0233492 PMID: 32469948
- 7. Liston SD et al.. 2015. Domain interactions control complex formation and polymerase specificity in the biosynthesis of the Escherichia coli O9a antigen.. J Biol Chem 290(2):1075-85 PMID: 25422321
- 8. Ke SB et al.. 2020. ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p.. Pathol Res Pract 216(3):152761 PMID: 31899049
